Dr. Vicini on Accelerated Partial Breast Irradiation in Low-Risk Breast Cancer

Frank A. Vicini, MD
Published: Thursday, Oct 29, 2015



Frank A. Vicini, MD, radiation oncologist, 21st Century Oncology of Michigan, discusses a European study that examined the efficacy of accelerated partial breast irradiation (APBI) versus conventional whole breast irradiation (WBI) in patients with low-risk breast cancer.

The multicenter European noninferiority phase III study demonstrated noninferiority of APBI compared with WBI for select patients with early-stage breast cancer. It is also the first large trial that addresses this topic, Vicini adds. Patients were closely followed, and techniques were done consistently.

Data from this study show that the paradigm for treating these select patients should change in centers beyond Europe, Vicini explains.



Frank A. Vicini, MD, radiation oncologist, 21st Century Oncology of Michigan, discusses a European study that examined the efficacy of accelerated partial breast irradiation (APBI) versus conventional whole breast irradiation (WBI) in patients with low-risk breast cancer.

The multicenter European noninferiority phase III study demonstrated noninferiority of APBI compared with WBI for select patients with early-stage breast cancer. It is also the first large trial that addresses this topic, Vicini adds. Patients were closely followed, and techniques were done consistently.

Data from this study show that the paradigm for treating these select patients should change in centers beyond Europe, Vicini explains.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Leveraging New Evidence in the Context of Evolving Early-Stage Treatment Standards in HER2-Positive Breast CancerJan 30, 20181.5
14th Annual School of Breast Oncology® OnlineFeb 10, 201825
Publication Bottom Border
Border Publication
x